Magenta Therapeutics
Magenta Therapeutics is focused in developing medicines to make cures possible for more patients with blood cancers, genetic diseases and autoimmune diseases.
Last updated on
About Magenta Therapeutics
Founded
2016Estimated Revenue
$10M-$50MEmployees
11-50Funding / Mkt. Cap
$397MCategory
Sector
Health CareIndustry Group
Pharmaceuticals, Biotechnology & Life SciencesIndustry
BiotechnologyLocation
City
CambridgeState
MassachusettsCountry
United StatesTech Stack (38)
